29 May 2023 , 10:37 AM
Result date: 30th May, 2023
Recommendation: Buy
Target price: Rs. 5,150
Analysts at IIFL Securities expect Apollo Hospitals Enterprise (Apollo) to witness a sequential improvement of 150-200 basis points in patient occupancies. The company’s revenue could grow 19% over the year-ago quarter and decline 1% sequentially.
Apollo’s EBITDA losses for 24/7 are likely to remain flat sequentially at Rs. 1.9 billion. Overall EBITDA could inch up 3% over the year-ago quarter, even as they could dip 5% on a sequential basis.
Profit After Tax (PAT) could grow 69% over the year ago quarter and decline 3% on a sequential basis.
Important management insights to watch out for:
|
March 2023 estimates |
YoY change |
QoQ change |
|
| Revenue (Rs. mn) |
42,317 |
19% |
(1)% |
| EBITDA (Rs. mn) |
4,791 |
3% |
(5)% |
| EBITDA margin (%) |
11.3% |
(174) bps |
(53) bps |
| Profit After Tax (Rs. mn) |
1,523 |
69% |
(3)% |
Source: IIFL Research
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
